UM School of Medicine Researchers Present Interim Results on Meningococcal Vaccine for Infants and Young Children in Africa
University of Maryland School of MedicineUniversity of Maryland School of Medicine (UMSOM) researchers, as part of the Infectious Diseases Clinical Research Consortium (IDCRC), provided an interim analysis showing that the pentavalent (NmCV-5) meningitis vaccine is safe for use in 9-month-old infants in the meningitis belt of sub-Saharan Africa.